References
Adamo, J. E., R. V. Bienvenu II, F. Dolz, M. Liebman, W. Nilsen, and S. J. Steele. 2020. Translation of digital health technologies to advance precision medicine: Informing regulatory science. Digital Biomarkers 4:1–12.
Alessa, A., and M. Faezipour. 2018. A review of influenza detection and prediction through social networking sites. Theoretical Biology & Medical Modelling 15(1).
Bloem, B. R., W. J. Marks, Jr., A. L. Silva de Lima, M. L. Kuijf, T. van Laar, B. Jacobs, M. M. Verbeek, R. C. Helmich, B. P. van de Warrenburg, L. Evers, J. intHout, T. van de Zande, T. M. Snyder, R. Kapur, and M. J. Meinders. 2019. The Personalized Parkinson Project: Examining disease progression through broad biomarkers in early Parkinson’s disease. BMC Neurology 19(1):160.
Bot, B. M., C. Suver, E. C. Neto, M. Kellen, A. Klein, C. Bare, M. Doerr, A. Pratap, J. Wilbanks, E. R. Dorsey, S. H. Friend, and A. D. Trister. 2016. The mPower study, Parkinson disease mobile data collected using ResearchKit. Scientific Data 3:160011.
Chaibub Neto, E., A. Pratap, T. M. Perumal, M. Tummalacherla, P. Snyder, B. M. Bot, A. D. Trister, S. H. Friend, L. Mangravite, and L. Omberg. 2019. Detecting the impact of subject characteristics on machine learning-based diagnostic applications. npj Digital Medicine 2(1):99.
Chan, Y.-F. Y., B. M. Bot, M. Zweig, N. Tignor, W. Ma, C. Suver, R. Cedeno, E. R. Scott, S. Gregory Hershman, E. E. Schadt, and P. Wang. 2018. The Asthma Mobile Health Study, smartphone data collected using ResearchKit. Scientific Data 5:180096.
Chari, A., D. Romanus, P. DasMahapatra, M. Hoole, M. Lowe, C. Curran, S. Campbell, and J. A. Bell. 2019. Patient reported factors in treatment satisfaction in patients with relapsed/refractory multiple myeloma (RRMM). Oncologist 24(11):1479–1487.
Coravos, A., J. C. Goldsack, D. R. Karlin, C. Nebeker, E. Perakslis, N. Zimmerman, and M. K. Erb. 2019a. Digital medicine: A primer on measurement. Digital Biomarkers 3(2):31–71.
Coravos, A., S. Khozin, and K. D. Mandl. 2019b. Developing and adopting safe and effective digital biomarkers to improve patient outcomes. npj Digital Medicine 2(1):14.
Coravos, A., M. Doerr, J. Goldsack, C. Manta, M. Shervey, B. Woods, and W. A. Wood. 2020. Modernizing and designing evaluation for connected sensor technologies in medicine. npj Digital Medicine 3:37.
Crouthamel, M., E. Quattrocchi, S. Watts, S. Wang, P. Berry, L. Garcia-Gancedo, V. Hamy, and R. E. Williams. 2018. Using a ResearchKit smartphone app to collect rheumatoid arthritis symptoms from real-world participants: Feasibility study. JMIR mHealth and uHealth 6(9):e177.
CTTI (Clinical Trials Transformation Initiative). 2019. Recommendations executive summary: Advancing the use of mobile technologies for data capture & improved clinical trials. https://www.ctti-clinicaltrials.org/sites/www.ctti-clinicaltrials.org/files/mobile-technologies-executive-summary.pdf (accessed July 7, 2020).
Daniel, G., M. McCellan, E. Richardson, and W. Nosair. 2016. Facilitating biomarker development: Strategies for scientific communication, pathway prioritization, data-sharing, and stakeholder collaboration. Washington DC: Duke-Margolis Center for Health Policy.
Das, G., C. Chung, C. Nebeker, M. Bietz, and C. Bloss. 2018. Privacy policies for apps targeted toward youth: Descriptive analysis of readability. JMIR mHealth and uHealth 6(1):e3.
Drinkwater, S., and Y. Schlesinger. 2019. 2019: A year to move purposefully and fix things. https://medium.com/positive-returns/2019-a-year-to-move-purposefully-and-fix-things-c3c60747409 (accessed September 3, 2019).
FDA (U.S. Food and Drug Administration). 2017. Multiple endpoints in clinical trials guidance for industry. https://www.fda.gov/media/102657/download (accessed June 25, 2020).
FDA. 2018. Pathways for biomarker integration in drug development. https://www.fda.gov/drugs/cder-biomarker-qualification-program/pathways-biomarker-integration-drug-development (accessed September 15, 2020).
FDA. 2019a. Digital Health Software Precertification (Pre-Cert) Program. https://www.fda.gov/medical-devices/digital-health/digital-health-software-precertification-pre-cert-program (accessed June 23, 2020).
FDA. 2019b. Postmarketing studies and clinical trials—Implementation of Section 505(o)(3) of the Federal Food, Drug, and Cosmetic Act Guidance for Industry. https://www.fda.gov/media/131980/download (accessed June 25, 2020).
FDA. 2020a. Postmarketing requirements and commitments: Reports. https://www.fda.gov/drugs/postmarket-requirements-and-commitments/postmarketing-requirements-and-commitments-reports (accessed June 20, 2020).
FDA. 2020b. CDER patient-focused drug development. https://www.fda.gov/drugs/development-approval-process-drugs/cder-patient-focused-drug-development (accessed June 25, 2020).
FDA. 2020c. FDA biomarker qualification submissions. https://www.fda.gov/drugs/cderbiomarker-qualification-program/biomarker-qualification-submissions (accessed July 22, 2020).
FDA. 2020d. Real world evidence. https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence (accessed July 22, 2020).
FNIH (Foundation for the National Institutes of Health). 2016. Framework for defining evidentiary criteria for biomarker qualification. https://fnih.org/sites/default/files/final/pdf/Evidentiary%20Criteria%20Framework%20Final%20Version%20Oct%2020%202016.pdf (accessed June 17, 2020).
Gambhir, S. S., T. J. Ge, O. Vermesh, and R. Spitler. 2018. Toward achieving precision health. Science Translational Medicine 10(430):eaao3612.
Goldsack, J., A. Coravos, J. P. Bakker, B. Bent, A. V. Downling, C. Fitzer-Attas, A. Godfrey, J. G. Godino, N. Gujar, E. Izmailova, C. Manta, B. Peterson, B. Vandendriessche, W. A. Wood, K. W. Wang, and J. Dunn. 2020. Verification, analytical validation, and clinical validation (v3): The foundation of determining fit-for-purpose for biometric monitoring technologies (BioMets). npj Digital Medicine 3:55.
Grant, A., G. Wolf, and C. Nebeker. 2019. Approaches to governance of participant-led research: A qualitative case study. BMJ Open 9:025633.
Herrmann, M., P. Boehme, A. Hansen, K. Jansson, P. Rebacz, J. P. Ehlers, T. Mondritzki, and H. Truebel. 2020. Digital competencies and attitudes toward digital adherence solutions among elderly patients treated with novel anticoagulants: Qualitative study. Journal of Medical Internet Research 22(1):e13077.
Hirsch, I. B., J. B. Welsh, P. Calhoun, S. Puhr, T. C. Walker, and D. A. Price. 2019. Associations between HbA1c and continuous glucose monitoring-derived glycaemic variables. Diabetic Medicine 36(12):1637–1642.
Hixson, J. D., D. Barnes, K. Parko, T. Durgin, S. Van Bebber, A. Graham, and P. Wicks. 2015. Patients optimizing epilepsy management via an online community: The POEM study. Neurology 85(2):129–136.
Huang, Q., T. Crumley, C. Walters, L. Cluckers, I. Heirman, R. Railkar, G. Bhatia, M. Cantor, C. Benko, E. S. Izmailova, S. Rottey, and S. A. Stoch. 2020. “In-house” data on the outside—a mobile health approach. Clinal Pharmacology & Therapeutics 107(4):948–956.
Izmailova, E. S., I. L. McLean, G. Bhatia, G. Hather, M. Cantor, D. Merberg, E. D. Perakslis, C. Benko, and J. A. Wagner. 2019. Evaluation of wearable digital devices in a phase I clinical trial. Clinical and Translational Science 12(3):247–256.
Johnson & Johnson. 2020. Johnson & Johnson launches Heartline™, the first-of-its-kind, virtual study designed to explore if a new iPhone app and Apple Watch can help reduce the risk of stroke. Press Release. https://www.jnj.com/johnson-johnson-launches-heartline-the-first-of-its-kind-virtual-study-designed-to-explore-if-a-new-iphone-app-and-apple-watch-can-help-reduce-the-risk-of-stroke (accessed July 7, 2020).
Kaiser, J. 2019. NIH says its 1-million-person health study is off to good start. Science, May 8. https://www.sciencemag.org/news/2019/05/nih-says-its-1-million-person-health-study-good-start (accessed June 20, 2020).
Kelly, C. M., and A. Shahrokni. 2016. Moving beyond Karnofsky and ECOG performance status assessments with new technologies. Journal of Oncology 6186543.
Khozin, S., and A. Coravos. 2019. Decentralized trials in the age of real world evidence and inclusivity in clinical investigations. Clinical Pharmacology & Therapeutics 106:25–27.
Khozin, S., G. Kim, and R. Pazdur. 2017. Regulatory watch: From big data to smart data: FDA’s INFORMED initiative. Nature Reviews Drug Discovery 16(5):306.
Matthews, S. C., M. J. McShea, C. L. Hanley, A. Ravitz, A. B. Labrique, and A. B. Cohen. 2019. Digital health: A path to validation. npj Digital Medicine 2:38.
Muriello, D., D. Ben-David, U. Ozertem, and R. Shilon. 2018. Under the hood: Suicide prevention tools powered by AI. Facebook Engineering. https://engineering.fb.com/ml-applications/under-the-hood-suicide-prevention-tools-powered-by-ai (accessed June 17, 2020).
NASEM (National Academies of Sciences, Engineering, and Medicine). 2016. Deriving drug discovery value from large-scale genetic bioresources: Proceedings of a workshop. Washington, DC: The National Academies Press.
NASEM. 2019. Virtual clinical trials: Challenges and opportunities: Proceedings of a workshop. Washington, DC: The National Academies Press.
Nebeker, C. 2020. mHealth research applied to regulated and unregulated behavioral health research. The Journal of Law, Medicine & Ethics 48(1 Supp1):49–59.
Nebeker, C., and A. López-Arenas. 2016. Building Research Integrity and Capacity (BRIC): An educational initiative to increase research literacy among community health workers and promotores. Journal of Microbiology & Biology Education 17(1):41–45.
Nebeker, C., R. Linares-Orozco, and K. Crist. 2015. A multi-case study of research using mobile imaging, sensing and tracking technologies to objectively measure behavior: Ethical issues and insights to guide responsible research practice. Journal of Research Administration 46(1):118–137.
Nebeker, C., T. Lagare, M. Takemoto, B. Lewars, K. Crist, C. Bloss, and J. Kerr. 2016. Engaging participants to inform the ethical conduct of mobile imaging, pervasive sensing and location tracking research. Translational Behavioral Medicine 6(4):577–586.
Nebeker, C., J. Harlow, R. Espinoza Giacinto, R. Orozco-Linares, C. Bloss, and N. Weibel. 2017a. Ethical and regulatory challenges of research using pervasive sensing and other emerging technologies: IRB perspectives. AJOB Empirical Bioethics 8(4):266–276.
Nebeker, C., K. Murray, C. Holub, J. Haughton, and E. M. Arredondo. 2017b. Acceptance of mobile health in communities underrepresented in biomedical research: Barriers and ethical considerations for scientists. JMIR mHealth and uHealth 5(6):e87.
Nebeker, C., R. Bartlett Ellis, and J. Torous. 2018. Digital health decision-making checklist: Designed for researchers. https://recode.health/dmchecklist (accessed August 14, 2020).
Nebeker, C., R. J. Bartlett Ellis, and J. Torous. 2020a. Development of a decision-making checklist tool to support technology selection in digital health research. Translational Behavioral Medicine 10(4):1004–1015.
Nebeker, C., R. Espinosa Giacinto, B. Azucena, A. López-Arenas, and M. Kalichman. 2020b. Prioritizing competencies for “research” promotores and community health workers, Health Promotion and Practice, March 31. https://journals.sagepub.com/doi/10.1177/1524839920913548 (accessed July 7, 2020).
Neto, E. C., A. Pratap, P. Perumal, M. Tummalacherla, B. M. Bot, L. Mangravite, and L. Omberg. 2019. A permutation approach to assess confounding in machine learning applications for digital health. Paper presented at 25th ACM SIGKDD Conference on Knowledge Discovery and Data Mining, Anchorage, AK, August 4–8, 2019.
NIH (National Institutes of Health). 2020. Phase 4, funding: Industry search filters. Clinical-Trials.gov. https://clinicaltrials.gov/ct2/results?term=sensors&age_v=&gndr=&type=&rslt=&phase=3&fund=2&Search=Apply (accessed June 30, 2020).
Ohri, N., B. Halmos, W. R. Bodner, H. Cheng, C. Guha, S. Kalnicki, and M. Garg. 2019. Daily step counts: A new prognostic factor in locally advanced non-small cell lung cancer? International Journal of Radiation Oncology Biology Physics 105(4):745–751.
Okun, S., and K. Goodwin. 2017. Building a learning health care community: By the people, for the people. Learning Health Systems 1:e10028.
Pharma Intelligence. 2019. Pharma R&D annual review 2019. https://pharmaintelligence.informa.com/~/media/informa-shop-window/pharma/2019/files/whitepapers/pharma-rd-review-2019-whitepaper.pdf (accessed June 24, 2020).
Pratap, A., E. C. Neto, P. Snyder, C. Stepnowsky, N. Elhadad, D. Grant, M. H. Mohebbi, S. Mooney, C. Suver, J. Wilbanks, L. Mangravite, P. J. Heagerty, P. Arean, and L. Omberg. 2020. Indicators of retention in remote digital health studies: A cross-study evaluation of 100,000 participants. npj Digital Medicine 3(1):21.
Radin, J. M., N. E. Wineinger, E. J. Topol, and S. R. Steinhubl. 2020. Harnessing wearable device data to improve state-level real-time surveillance of influenza-like illness in the USA: A population-based study. The Lancet Digital Health 2(2):e85–e93.
Ramirez, E., N. Marinsek, B. Bradshaw, R. Kanard, and L. Foschini. 2020. Continuous digital assessment for weight loss surgery patients. Digital Biomarkers 4(1):13–20.
Ross, C., and E. Brodwin. 2020. Hospitals turn to big tech companies to store and analyze their data. STAT News. https://www.statnews.com/2020/03/12/hospitals-big-tech-store-analyze-data-privacy (accessed July 7, 2020).
Saeb, S., L. Lonini, A. Jayaraman, D. C. Mohr, and K. P. Kording. 2017. The need to approximate the use-case in clinical machine learning. GigaScience 6(5):1–9.
Servick, K. 2020. Cellphone tracking could help stem the spread of coronavirus. Is privacy the price? Science Magazine, March 22, 2020. https://www.sciencemag.org/news/2020/03/cellphone-tracking-could-help-stem-spread-coronavirus-privacy-price (accessed May 7, 2020).
Shiffman S., A. A. Stone, and M. R. Hufford. 2008. Ecological momentary assessment. Annual Reviews of Clinical Psychology 4:1–32.
Snipelisky, D., J. Kelly, J. A. Levine, G. A. Koepp, K. J. Anstrom, S. E. McNulty, R. Zakeri, G. M. Felker, A. F. Hernandez, E. Braunwald, and M. M. Redfield. 2017. Accelerometer-measured daily activity in heart failure with preserved ejection fraction: Clinical correlates and association with standard heart failure severity indices. Circulation: Heart Failure 10(6):e003878.
Trajkovic, G. 2008. Measurement: accuracy and precision, reliability and validity. In W. Kirch (ed.), Encyclopedia of Public Health. Dordrecht, The Netherlands: Springer.
Tung, J. Y., R. J. Shaw, J. M. Hagenkord, M. Hackmann, M. Muller, S. H. Beachy, V. M. Pratt, S. F. Terry, A. K. Cashion, and G. S. Ginsburg. 2018. Accelerating precision health by applying the lessons learned from direct-to-consumer genomics to digital health technologies. Discussion paper. Washington, DC: National Academy of Medicine. https://nam.edu/accelerating-precision-health-by-applying-the-lessons-learned-from-direct-to-consumer-genomics-to-digital-health-technologies (accessed July 7, 2020).
Upadhaya, S., J. X. Yu, C. Oliva, M. Hooton, J. Hodge, and V. M. Hubbard-Lucey. 2020. Impact of COVID-19 on oncology clinical trials. Nature Reviews Drug Discovery 19:376–377.
Vayena, E., T. Hausermann, A. Adjekum, and A. Blasimme. 2018. Digital health: Meeting the ethical and policy challenges. Swiss Medical Weekly 148:w14571.
Wang, S., K. Bolling, W. Mao, J. Reichstadt, D. Jeste, H. C. Kim, and C. Nebeker. 2019. Technology to support aging in place: Older adults’ perspectives. Healthcare (Basel, Switzerland) 7(2):60.
Wang, S., E. E. Lee, B. Zywicki, H. C. Kim, D. Jeste, and C. Nebeker. 2020. Predictive analytics and the return of “research” information to participants. In J. Spohrer and C. Leitner (eds.), Advances in the human side of service engineering. AHFE 2020. Advances in Intelligent Systems and Computing, vol. 1208. Springer, Cham. http://doi-org-443.webvpn.fjmu.edu.cn/10.1007/978-3-030-51057-2_20.
Webster, E. D., M. Tummalacherla, M. Higgins, D. Wing, E. Ashely, V. E. Kelly, M. V. McConnell, E. D. Muse, J. Olgin, L. Mangravite, J. Godino, M. Kellen, and L. Omberg. 2020. Heart snapshot: A broadly validated smartphone measure of VO2 max for collection of real world data. bioRxiv 185314.
This page intentionally left blank.
